Cormorant Asset Management, LP Omeros Corp Call Options Transaction History

Cormorant Asset Management, LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2020 Nov 16, 2020	BUY	$9.57 - $21.32 $9.57 Million - $21.3 Million	1,000,000 New	1,000,000 $10.1 Million
Q1 2019 May 15, 2019	SELL	$11.65 - $17.72 $2.12 Million - $3.22 Million	-181,700 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$10.72 - $16.73 $10.2 Million - $16 Million	-955,200 Reduced 84.02%	181,700 $2.02 Million
Q3 2018 Nov 14, 2018	BUY	$17.73 - $26.69 $2.98 Million - $4.48 Million	167,900 Added 17.33%	1,136,900 $27.8 Million
Q1 2018 May 15, 2018	SELL	$9.0 - $20.16 $7.03 Million - $15.7 Million	-781,000 Reduced 44.63%	969,000 $10.8 Million
Q4 2017 Feb 14, 2018	BUY	$13.26 - $22.86 $23.2 Million - $40 Million	1,750,000	1,750,000 $34 Million

123

25.1M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $575M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.